What is Repligen's common stock?

Repligen (RGEN) reported common stock of $564K in Q1 2026.

How has Repligen's common stock changed year-over-year?

Repligen's common stock increased by 0.4% year-over-year, from $562K to $564K.

What is the long-term trend for Repligen's common stock?

Over 5 years (2020 to 2025), Repligen's common stock has grown at a 0.5% compound annual growth rate (CAGR), from $548K to $563K.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Repligen RGEN Common Stock

Common Stock at other companies

TEC

Bio-TechneTECH

$1.57M-0.2%

RevvityRVTY

300M0.0%

DanaherDHR

2B+22,122%

Agilent TechnologiesA

2B0.0%

Charles River LaboratoriesCRL

120M0.0%

WAT

Waters CorporationWAT

$2M+22.6%

Other financials

Income statement

See full

Revenue$194.3M+14.8%

Gross profit$108.3M+18.5%

Operating income$15.9M+142%

Net income$8.3M+42.9%

EPS (diluted)$0.15+50.0%

Balance sheet

See full

Cash & equivalents$582.7M-16.4%

Total debt$687.6M+346%

Total equity$2.1B+6.0%

Total assets$2.9B+2.8%

Cash flow

See full

Operating cash flow$28.3M+88.6%

CapEx$4.7M+32.2%

Free cash flow$23.6M+106%

Valuation

See full

Market cap$7.45B-7.1%

Enterprise value$7.55B+2.1%

P/E144.9×—

P/S10.1×-0.1×

Profitability

See full

Gross margin49.5%+2.7pp

Operating margin1.5%-14.0pp

Net margin17.1%-3.7pp

FCF margin21.2%+6.1pp

Returns & leverage

See full

Return on equity2.5%+1.9pp

Debt / equity0.3×+0.2×

Current ratio9.2×+2.4×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Repligen’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Repligen's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Repligen's common stock?: Repligen (RGEN) reported common stock of $564K in Q1 2026.
How has Repligen's common stock changed year-over-year?: Repligen's common stock increased by 0.4% year-over-year, from $562K to $564K.
What is the long-term trend for Repligen's common stock?: Over 5 years (2020 to 2025), Repligen's common stock has grown at a 0.5% compound annual growth rate (CAGR), from $548K to $563K.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).